2Mitchell A, Philipp T. Women and hypertension[J]. Herz,2005, 30(5) : 401-404.
3Gu d, Wildman PR, Wu X, et al. Incidence and predictors of hypertension over 8 years among Chinese men and women[J].Hypertens,2007,25(3) :517-523.
4de Simone G, Wachtell K, Palmieri V, et al. Body build and risk of eardiovaseuIar events in hypertension and left ventrieular hypertrophy the LIFE (losartan intervention for endpoint reduction in hypertension) study[J].rculation, 2005,111 (15) ; 1924-1931.
5Ferdinand KC, Kleinpeter MA. Management of hypertension and dyslipidemia[J]. Curr Hypertens Rep,2006,8(6):489-496.
8Haq AN. Hyperreactio luteinalis associated with pregnancy induced hypertension[J]. J Coll Physicians Surg Pak,2010,20(2): 137-139.
9Wild RA, Carmina E, Diamanti-Kandarakis E, etal. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (AE PCOS) society[J]. J Clin Endocrinol Metab, 2010, 95 (5): 2038- 2049.
7Peterson LS. Contraceptive use in the United States: 1982 -90. Adv Data, 1995, (260) :1 -15.
8Baillargeon JP, McClish DK, Essah PA et al. Association between the current use of low - dose oral contraceptives and cardiovascular arterial disease: a meta - analysis. J Clin Endocrinol Metab, 2005, 90 ( 7 ) : 3863 - 3870.
9Li Y, Zhou L, Coulter D et al. Prospective cohort study of the association between use of low - dose oral contraceptives and stroke in Chinese women. Pharmacoepidemiol Drug Saf , 2006, 15 (10) : 726 - 734.
10Curtis KM, Mohllajee AP, Martins SL et al. Combined oral contraceptive use among women with hypertension : a systematic review. Contraception, 2006, 73(2) : 179 - 188.
